Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.005
+0.055 (2.82%)
Oct 8, 2025, 1:38 PM EDT - Market open

Innate Pharma Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Innate Pharma stock has a target of 2.00, which predicts a -0.25% decrease from the current stock price of 2.01.

Price Target: $2.00 (-0.25%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$2.00$2.00$2.00$2.00
Change-0.25%-0.25%-0.25%-0.25%

Analyst Ratings

The average analyst rating for Innate Pharma stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy111100
Buy000000
Hold000022
Sell000000
Strong Sell000000
Total111122

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Leerink Partners
Leerink Partners
Hold
Downgrades
$10$2
HoldDowngrades$10$2-0.25%Sep 18, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
HoldDowngradesn/an/aSep 18, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12$11
Strong BuyReiterates$12$11+448.63%Apr 24, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12
Strong BuyReiterates$12+473.57%Mar 28, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12
Strong BuyReiterates$12+473.57%Feb 6, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
90.74M
from 20.12M
Increased by 350.96%
Revenue Next Year
120.61M
from 90.74M
Increased by 32.92%
EPS This Year
0.42
from -0.61
EPS Next Year
0.32
from 0.42
Decreased by -23.23%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
69.77M24.70M57.67M61.64M20.12M90.74M120.61M
Revenue Growth
-18.35%-64.60%133.47%6.88%-67.36%350.96%32.92%
EPS
-0.81-0.66-0.73-0.09-0.610.420.32
EPS Growth
-------23.23%
Forward PE
-----4.155.40
No. Analysts
-----54
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High193.2M302.4M
Avg90.7M120.6M
Low12.7M6.6M

Revenue Growth

Revenue Growth20252026202720282029
High
860.2%
233.3%
Avg
351.0%
32.9%
Low
-37.0%
-92.7%

EPS Forecast

EPS202520262027
High1.411.88
Avg0.420.32
Low-0.55-0.57

EPS Growth

EPS Growth202520262027
High-
351.1%
Avg-
-23.2%
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.